Clinical Trial Update: Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate; the trial completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-01